APA (7th ed.) Citation

K, R., J, R., JN, R., T, L., M, S., RR, C., & RF, G. (2019). A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: A review on the emerging data. Dove Medical Press.

Chicago Style (17th ed.) Citation

K, Rana, Reid J, Rosenwasser JN, Lewis T, Sheikh-Ali M, Choksi RR, and Goldfaden RF. A Spotlight on Alirocumab in High Cardiovascular Risk Patients with Type 2 Diabetes and Mixed Dyslipidemia: A Review on the Emerging Data. Dove Medical Press, 2019.

MLA (8th ed.) Citation

K, Rana, et al. A Spotlight on Alirocumab in High Cardiovascular Risk Patients with Type 2 Diabetes and Mixed Dyslipidemia: A Review on the Emerging Data. Dove Medical Press, 2019.